Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 6:27 pm Sale | 2024-12-31 | 13G | BIOAGE LABS INC BIOA | RA Capital Management, L.P. | 1,310,589 3.700% | -900,000 (-40.71%) | Filing History |
| 2025-02-14 6:27 pm Sale | 2024-12-31 | 13G | AN2 THERAPEUTICS INC ANTX | RA Capital Management, L.P. | 0 0.000% | -1,999,997 (Position Closed) | Filing History |
| 2025-02-14 6:26 pm Sale | 2024-12-31 | 13G | ALTO NEUROSCIENCE INC ANRO | RA Capital Management, L.P. | 0 0.000% | -2,075,154 (Position Closed) | Filing History |
| 2025-02-14 6:25 pm Purchase | 2024-12-31 | 13G | MONOPAR THERAPEUTICS INC MNPR | RA Capital Management, L.P. | 620,116 9.900% | 108,909 (+21.30%) | Filing History |
| 2025-02-14 6:24 pm Unchanged | 2024-12-31 | 13G | ZURA BIO LTD ZURA | RA Capital Management, L.P. | 3,217,503 4.900% | 0 (Unchanged) | Filing History |
| 2025-02-03 5:39 pm Purchase | 2025-01-30 | 13D | 89BIO INC ETNB | RA Capital Management, L.P. | 20,013,733 15.100% | 5,759,435 (+40.40%) | Filing History |
| 2024-12-30 6:51 pm Purchase | 2024-12-26 | 13D | VOR BIOPHARMA INC.COM VOR | RA Capital Management, L.P. | 1,985,493 31.900% | 846,476 (+74.32%) | Filing History |
| 2024-12-06 5:30 pm Purchase | 2024-11-29 | 13G | ALECTOR INC ALEC | RA Capital Management, L.P. | 9,695,228 9.900% | 9,695,228 (New Position) | Filing History |
| 2024-12-05 6:55 pm Purchase | 2024-11-27 | 13G | KURA ONCOLOGY INC KURA | RA Capital Management, L.P. | 4,368,998 5.600% | 4,368,998 (New Position) | Filing History |
| 2024-11-26 5:32 pm Purchase | 2024-11-26 | 13D | CIDARA THERAPEUTICS INC NE CDTX | RA Capital Management, L.P. | 1,092,796 9.990% | 389,716 (+55.43%) | Filing History |
| 2024-11-22 4:12 pm Purchase | 2024-11-15 | 13G | ARCELLX INC ACLX | RA Capital Management, L.P. | 2,787,327 5.200% | 2,787,327 (New Position) | Filing History |
| 2024-11-18 8:19 pm Unchanged | 2024-11-14 | 13D | 89BIO INC ETNB | RA Capital Management, L.P. | 14,254,298 11.900% | 0 (Unchanged) | Filing History |
| 2024-11-15 5:05 pm Sale | 2024-11-13 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | RA Capital Management, L.P. | 5,098,211 11.000% | -103,934 (-2.00%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | RA Capital Management, L.P. | 5,202,145 9.990% | 1,038,934 (+24.96%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | ASTRIA THERAPEUTICS INC ATXS | RA Capital Management, L.P. | 5,105,213 9.000% | 692,063 (+15.68%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | NEWAMSTERDAM PHARMA CO NV SHS NAMS | RA Capital Management, L.P. | 9,095,589 9.990% | 898,256 (+10.96%) | Filing History |
| 2024-11-14 5:46 pm Sale | 2024-09-30 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | RA Capital Management, L.P. | 9,710,428 16.100% | -396,972 (-3.93%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | GERON CORP GERN | RA Capital Management, L.P. | 63,319,553 9.990% | 8,174,051 (+14.82%) | Filing History |
| 2024-11-14 5:46 pm Sale | 2024-09-30 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | RA Capital Management, L.P. | 761,955 4.300% | -473,644 (-38.33%) | Filing History |
| 2024-11-14 5:46 pm Sale | 2024-09-30 | 13G | REGULUS THERAPEUTICS INC P RGLS | RA Capital Management, L.P. | 766,834 1.200% | -5,483,166 (-87.73%) | Filing History |